Related Experiment Video
Updated: May 29, 2025
08:19
Hollow Microneedle-based Sensor for Multiplexed Transdermal Electrochemical Sensing
Published on: June 1, 2012
14.3K
Microneedle-Based Approaches for Skin Disease Treatment
Yanhua Han1, Xiaoyu Qin1, Weisen Lin1
1State Key Laboratory of Traditional Chinese Medicine Syndrome, Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, 510405, People's Republic of China.
Nano-Micro Letters
|February 5, 2025
Summary
Microneedles (MNs) offer a safe and effective way to deliver drugs for various skin diseases. While promising, challenges like low drug loading and mechanical strength limit their widespread clinical use.
Area of Science:
- Dermatology
- Nanotechnology
- Drug Delivery Systems
Background:
- Microneedles (MNs) are an advanced transdermal drug delivery strategy.
- They offer improved safety, efficacy, and painless administration compared to conventional methods.
- MNs are increasingly utilized for delivering insoluble drugs and bioactive substances for enhanced therapeutic effects.
Purpose of the Study:
- To review the current applications of MNs in treating various skin diseases.
- To discuss the clinical potential and future directions of MNs in dermatology.
- To identify challenges and opportunities in MN-based therapies for skin conditions.
Main Methods:
- Literature review of microneedle applications in skin disease treatment.
- Analysis of current clinical uses and preparation methods for MNs.
- Discussion of challenges and future research avenues for MN technology.
Main Results:
- Microneedles show significant potential in treating diverse skin conditions including psoriasis, vitiligo, alopecia, acne, and melanoma.
- Diverse preparation methods allow MNs to meet various application requirements.
- MNs have successfully addressed limitations associated with insoluble drugs and expanded the use of bioactive substances.
Conclusions:
- Microneedles represent a promising advancement in transdermal drug delivery for dermatological conditions.
- Key challenges such as low drug loading and poor mechanical strength need to be overcome for broader clinical implementation.
- Further research is crucial to fully realize the potential of MN-based therapies in treating skin diseases.
